Category: Medication safety

  • Blood pressure medication in older adults: the case for monitoring

    Read this first. High blood pressure is a serious condition and treating it prevents strokes and heart attacks. Nothing on this page is a reason to stop or reduce a blood pressure medication. Stopping antihypertensive medication without medical supervision can be dangerous. The point of this article is that treatment needs ongoing review — which is a reason to talk to a clinician, not to act alone.

    Hypertension is one of the most common conditions in older adults; research has put the prevalence among Western populations over 60 at around 60 percent. It is so routine that the diagnosis, once made, often stops being questioned — and so does the prescription.

    What the study found

    A study published in Age and Ageing analyzed more than 11,000 patients over the age of 70 and found that a substantial number — over 1,200 of them — were taking antihypertensive medication while measuring hypotensive, meaning their blood pressure was below the normal range rather than above it.

    The researchers linked persistent low blood pressure in this group to increased mortality and hospital admission.

    Why this happens

    It is rarely anyone’s mistake in particular. It is what happens when a correct decision is never revisited. Blood pressure genuinely falls with age, with weight loss, with illness, and with reduced activity. A dose that was right at 68 can be too much at 78, and nobody notices unless somebody measures.

    The consequences of overshooting are not abstract in an older person: dizziness on standing, falls, fainting, confusion, and hospital admissions that follow from those.

    What the researchers recommended

    Not stopping treatment — monitoring it. Consistent follow-up after starting or changing an antihypertensive, and awareness that hypotension is a real risk in a frail population, not just hypertension.

    Why this matters more in home care than in a clinic

    Blood pressure is measured in a clinic, sitting down, after a rest. The problems caused by it being too low happen somewhere else entirely — standing up from a low chair, getting out of bed at 3 a.m., turning quickly in a bathroom. A reading taken in the right conditions can look perfectly acceptable while the person is nearly fainting at home every morning.

    This is called orthostatic hypotension — a drop in blood pressure on standing — and it is both common and under-detected in older adults. It is also one of the most direct causes of the falls that end independent living. The information that closes the gap between the clinic reading and the reality is behavioural, and it comes from whoever is in the house.

    What this means for day-to-day care. This is one of the clearest examples of why the person who is there every day matters. Dizziness when standing up, unsteadiness after getting out of bed, new confusion, near-faints, or a pattern of falls in the morning are all worth reporting to the family and the person’s clinician. A personal care attendant does not administer medication or make clinical judgments — but noticing and reporting a pattern is exactly the kind of information that gets a dose reviewed.

    Sources

    This article is general information, not medical advice. It describes published research; it is not a recommendation for you or the person you care for. Never start, stop or change a prescribed medication because of something you read here — talk to the prescribing clinician first. Communicare Elite provides non-medical personal care through Missouri’s Consumer Directed Services program and does not provide medical advice or treatment.

  • Cholesterol in older adults: what the debate is actually about

    Read this first. Statins and other cholesterol-lowering medicines are prescribed to prevent heart attacks and strokes, and large randomized trials show they do. Do not stop, reduce or skip a cholesterol medication because of anything on this page. If you have questions about whether yours is still right for you, that is a conversation to have with the clinician who prescribed it.

    An earlier version of this article presented one side of a contested question as settled fact, and told readers that statin benefits were “grossly exaggerated.” That was not a fair summary of the evidence, and it has been rewritten.

    What the review reported

    In 2016 a group led by Uffe Ravnskov published a systematic review in BMJ Open covering 19 cohort studies — about 68,000 older people in total. The authors reported that in most of the cohorts they examined, high LDL cholesterol was not associated with higher all-cause mortality, and in a number of cohorts the association ran the other way: higher LDL, lower mortality.

    Why it was criticized

    Heavily, and by mainstream bodies. The main objections:

    • Method. The Oxford Centre for Evidence-Based Medicine and others argued the review relied on aggregated published summaries rather than individual participant data, an approach prone to bias, and that its selection and analysis were not robust.
    • It contradicts trial evidence. Observational associations between cholesterol level and death are not the same thing as testing what happens when you lower it. Randomized trials of cholesterol-lowering therapy consistently show reduced heart attacks and strokes, including in older participants.
    • Reverse causation is a known trap here. Serious illness — cancer, frailty, advanced heart failure — lowers cholesterol. In an elderly cohort, low LDL can be a marker of being ill rather than a cause of dying, which can manufacture an apparent inverse association.

    What is genuinely unsettled

    There is a real and legitimate clinical question underneath the controversy, and it is narrower than the headlines: how much benefit does starting a statin for primary prevention give someone in their late 80s with a limited life expectancy and a long list of other medications? Guidelines are genuinely more cautious there, and deprescribing near the end of life is an accepted part of good geriatric practice.

    That is a very different proposition from stopping a statin in someone who has already had a heart attack. “Is this still the right medication for me?” is a good question to bring to a clinician. “I read online that cholesterol does not matter” is not a plan.

    What this means for day-to-day care. Personal care attendants do not advise on medication and should not be drawn into it. If the person you care for raises doubts about their prescriptions, the right response is to encourage them to raise it with their clinician or their family — not to agree, disagree, or look it up for them. What is worth reporting is practical: pills going untaken, confusion about doses, or new side effects like muscle pain.

    Sources

    This article is general information, not medical advice. It describes published research; it is not a recommendation for you or the person you care for. Never start, stop or change a prescribed medication because of something you read here — talk to the prescribing clinician first. Communicare Elite provides non-medical personal care through Missouri’s Consumer Directed Services program and does not provide medical advice or treatment.

Communicare Elite

4477 Woodson Rd, Suite 106, St. Louis, MO 63134

Phone: (314) 809-6655
Text: (314) 886-5902
Fax: (314) 481-3037
Email: info@communicareelite.com

Monday–Friday, 9:00 AM–5:00 PM Central. An enrolled MO HealthNet Consumer Directed Services vendor.


Emergencies: call 911. Mental health crisis: call or text 988. Adult abuse, neglect or exploitation: Missouri hotline 1-800-392-0210.

Communicare Elite is a trade name of Communicare Elite, LLC. Consumer Directed Services is a MO HealthNet program administered by the Missouri Department of Health and Senior Services; eligibility and authorized hours are determined by the state, not by Communicare Elite. We serve Missouri only.

© Communicare Elite, LLC. All rights reserved.